About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Melanoma Clinical Trials | 3,350 Studies Recruiting

Clinical TrialsMelanoma

Melanoma Clinical Trials

Browse 3,350 clinical trials for melanoma. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2961-2980 of 3,350 trials

UnknownA Study of BCD-135 in Patients With Advanced Solid TumorsA Multicenter Open-Label Single-Arm Multi-Cohort Phase I Study of Pharmacokinetics, Safety, and Immunogenicity of BCD-135 (JSC BIOCAD, Russia) in Patients with Advanced Solid…NCT03464032·Saint Petersburg TerminatedTreatment of Resistant Metastatic Melanoma Using Decitabine, Temozolomide and PanobinostatThe purpose of this study is to treat metastatic melanoma with a combination of standard chemotherapy (decitabine and Temozolomide in a dose escalation scheme) with an study drug…NCT00925132·Iowa City, Iowa Not yet recruitingSI-B036-ST-101 in Advanced/Metastatic Solid TumorsThe objective of the study is to evaluate the safety and tolerability of SI-B036 in participants with solid tumors who have received at least one prior line of therapy for…NCT07857616·New Haven, Connecticut and 6 others UnknownTilting of Radioactive Plaques After Initial Accurate Placement for Treatment of Uveal MelanomaPlaque radiotherapy is a common treatment for uveal melanoma. However, local failure has been reported in up to 20% of patients.NCT00459849·St Louis, Missouri

Related Searches

skin cancertrials

Data from ClinicalTrials.govTerms

CompletedGranulocyte Macrophage-Colony Stimulating Factor and Ipilimumab as Therapy in MelanomaThe study is an open-label, single arm single Center Phase II study to evaluate the safety and efficacy of the combination of Granulocyte Macrophage-Colony Stimulating Factor…NCT01363206·San Francisco, California and 1 other

TerminatedTovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid TumorsThis is a Phase 2, multi-center, open-label to evaluate the efficacy and safety of tovorafenib (DAY101) in participants ≥12 years of age with recurrent or progressive melanoma or…NCT04985604·Los Angeles, California and 19 others

Terminated[18F]Dabrafenib Molecular Imaging in Melanoma Brain MetastasisIn this feasibility study, \[18F\]dabrafenib will be used as radioactive tracer.NCT02700763·Groningen

Enrolling by invitationProspective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor MicroenvironmentBackground: Many advances have been made in cancer treatments, but more research is needed.NCT05600933·Bethesda, Maryland

CompletedStudy to Analyze Mutations in V600 BRAF Oncogen in Participants With Metastatic MelanomaThis is a national, multicenter, cross-sectional epidemiological study in adult Spanish participants diagnosed with advanced or metastatic melanoma.NCT02663232·Palma de Mallorca, Balearic Islands and 32 others

UnknownPhase II/III Clinical Study CSF470 Plus BCG Plus GM-CSF vs IFN Alpha 2b in Stage IIB, IIC and III Melanoma PatientsRandomized, open, Phase II-III study, comparative between treatment with CSF-470 vaccine , allogeneic, irradiated with BCG and molgramostin (rHuGM-CSF) as adjuvants and interferon…NCT01729663·Buenos Aires, Buenos Aires F.D.

RecruitingORACLE: Observation of ResiduAl Cancer With Liquid Biopsy EvaluationThe purpose of ORACLE is to demonstrate the ability of a novel ctDNA assay developed by Guardant Health to detect recurrence in individuals treated for early-stage solid tumors.NCT05059444·Birmingham, Alabama and 56 others

RecruitingIDOV-Immune for Advanced Solid TumorsThis is a Phase I clinical trial evaluating an investigational treatment called IDOV-Immune, a type of oncolytic virus therapy, for adults with advanced solid tumors that have not…NCT06910657·St Louis, Missouri and 4 others

Active not recruitingA Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.The purpose of this clinical trial is to learn about the safety and effects of the study medicine (called PF-07799933) administered as a single agent and in combination with other…NCT05355701·Fayetteville, Arkansas and 39 others

CompletedIn Vitro Expanded Autologous Invariant Natural Killer Cells in CancerThe purpose of this research study is to determine whether we can purify and grow a population of cells from the participants blood (iNKT cells) and then safely give them back to…NCT00631072·Boston, Massachusetts and 1 other

CompletedGenetically Modified Therapeutic Autologous Lymphocytes Followed by Aldesleukin in Treating Patients With Stage III or Metastatic MelanomaThis phase I/II trial studies how well genetically modified therapeutic autologous lymphocytes (patient's own white blood cells) followed by aldesleukin work in treating patients…NCT01740557·Houston, Texas

RecruitingPsilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment DisorderThis study is assessing the efficacy and safety of NPX-5 in psilocybin-assisted psychotherapy for the treatment of adjustment disorder due to cancer diagnosis. Who is it for?NCT07072728·Abbotsford, Victoria and 2 others

TerminatedTreatment With Dasatinib in Patients With Acral Lentiginous, Mucosal, or Chronic Sun-damaged MelanomaThe goal of this clinical research study is to compare how the drug Sprycel (dasatinib) can help to control the tumor in Patients With Acral Lentiginous, Mucosal, or Chronic…NCT01092728·Houston, Texas

RecruitingFMT in Checkpoint Inhibitor-mediated Diarrhea and ColitisThe goal of this clinical trial is to determine the outcome of patients with immune checkpoint inhibitor-mediated diarrhea/colitis (IMC) treated with faecal microbiota…NCT06206707·Aarhus N

CompletedA Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced MalignanciesThis is a Phase 1, open-label, first-in-human (FIH) dose-escalation study designed to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and…NCT02571036·Scottsdale, Arizona and 25 others

CompletedYttrium-90 Radioembolization Using Glass Microspheres (TheraSphere) for Patients With Liver MetastasesThis is a prospective pilot study designed to document safety and efficacy of liver-directed therapy for colorectal, neuroendocrine, cholangiocarcinoma, melanoma, and breast…NCT01290536

PreviousPage 149 of 168Next